National, May 21, 2025
Zydus Wellness, a leading science-backed FMCG company, has unveiled its new corporate brand identity, marking a defining step in its transformation journey. With consumers at the heart, the refreshed identity reflects the company’s commitment to blending scientific credibility with empathetic care to deliver wellness that is trusted, inclusive, and future ready.
The identity refresh positions Zydus Wellness as an organization rooted in science, driven by compassion, and inspired by the communities it serves. At the heart of this transformation is the promise of ‘us’, a commitment to grow inclusively and impactfully with every stakeholder who is part of the brand’s journey.
The dual-toned palette of teal and purple reflects Zydus Wellness’ core belief that true wellness is built where scientific innovation meets human connection. The teal heart, representing the consumer, stands for science, trust, and clarity, the foundation of the company’s product development. The purple heart embodies warmth, care, and inclusivity, honoring the people and partnerships that fuel the company’s journey. Together, these hearts and hues form a powerful ripple that nourishes, nurtures and energizes lives, communities, and every stakeholder touched by the brand.
Speaking on the occasion, Tarun Arora, CEO & Whole Time Director, Zydus Wellness, said, “As the wellness landscape continues to evolve, the refreshed brand identity affirms our intent to embrace change boldly, expand our science-backed portfolio, and deepen our impact through digital wellness innovations and sustainable business practices. The transformation is not just visual, it reflects Zydus Wellness’ renewed focus on becoming a more inclusive, path-breaking, and consumer-first organization with one shared purpose.”
In FY 25, Zydus Wellness Limited reported a growth of 16.2% in Net Sales on a consolidated basis, which stood at ₹ 26,912 million. Net profit for the period (excluding exceptional items and one-time deferred tax assets) was up by 30.0% and stood at ₹ 3,410 million. EBITDA for the period rose by 23.2% to ₹ 3,797 million.
